Customer Support: +919024236503

Need Help?

  • Share via whatsapp

Voglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg - Explore......

Aug 01, 2024

TRIOGLIMITERIS 1/0.2 

Voglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg

Introduction

TRIOGLIMITERIS 1/0.2 is a combination medication used to manage type 2 diabetes mellitus. It contains three active ingredients: Voglibose (0.2 mg), Glimepiride (1 mg), and Metformin Hydrochloride (500 mg). This synergistic formulation helps in controlling blood sugar levels by targeting different mechanisms. This article provides an in-depth look at the uses, dosage, side effects, price, and overall conclusion of TRIOGLIMITERIS 1/0.2.

Uses

TRIOGLIMITERIS 1/0.2 is primarily used to manage type 2 diabetes mellitus in adults. Each of its components plays a specific role in controlling blood glucose levels:

  1. Voglibose (0.2 mg): Voglibose is an alpha-glucosidase inhibitor that delays the absorption of carbohydrates in the intestine, thereby reducing postprandial (after meal) blood glucose spikes.
  2. Glimepiride (1 mg): Glimepiride is a sulfonylurea that stimulates the release of insulin from pancreatic beta cells, thereby lowering blood glucose levels.
  3. Metformin Hydrochloride (500 mg): Metformin is a biguanide that decreases hepatic glucose production and improves insulin sensitivity, allowing better utilization of glucose by the body.

This combination medication is particularly beneficial for patients who require multiple therapeutic interventions to achieve optimal glycemic control.

Dosage

The dosage of TRIOGLIMITERIS 1/0.2 should be individualized based on the patient's current treatment regimen, effectiveness, and tolerability. It is typically taken once or twice daily with meals to minimize gastrointestinal side effects and to enhance its efficacy.

Important Dosage Instructions:

  1. Starting Dose: The starting dose is usually one tablet taken once daily with the main meal.
  2. Adjustments: Dosage adjustments should be made gradually based on the patient’s blood glucose response. Monitoring of blood glucose levels is essential to determine the appropriate dosage.
  3. Dosage missing: Take the missing dose as soon as you remember it. If the next dose is almost due, skip the missed one and go back to your regular dosing plan. Never take two doses to make up for one that you missed.
  4. Consistency: Take the medication at the same time each day to maintain consistent blood levels and optimize therapeutic effects.

Side Effects

Like any drug, TRIOGLIMITERIS 1/0.2 could have adverse effects. While many people do not experience significant issues, it is important to be aware of potential adverse effects.

Common Side Effects:

  1. Gastrointestinal Issues: Metformin may cause nausea, vomiting, diarrhea, and abdominal discomfort, particularly at the start of treatment. Taking the medication with food can help mitigate these effects.
  2. Hypoglycemia: Glimepiride may cause low blood sugar levels, especially when taken with other antidiabetic medications or if meals are skipped.
  3. Flatulence and Bloating: Voglibose may cause increased flatulence and abdominal bloating due to its action on carbohydrate absorption.

Serious Side Effects:

  1. Metformin may, however infrequently, result in lactic acidosis, a dangerous metabolic side effect. Symptoms include muscle pain, difficulty breathing, stomach pain, dizziness, and irregular heartbeats. If these symptoms appear, you need to get medical help right away.
  2. Reactions: Allergic reactions can cause rash, itching, swelling, extreme vertigo, and breathing difficulties. Seek immediate medical help if any signs of an allergic reaction appear.

Price

The price of TRIOGLIMITERIS 1/0.2 can vary depending on the region, pharmacy, and whether it is purchased as a branded or generic product. On average, the cost for a month's supply of TRIOGLIMITERIS 1/0.2 is approximately INR 500-800. It is advisable to compare prices from different pharmacies and consider purchasing in bulk to save on costs. Additionally, some health insurance plans may cover part of the expense, so it is beneficial to check with the insurance provider.

Conclusion

TRIOGLIMITERIS 1/0.2, a combination of Voglibose (0.2 mg), Glimepiride (1 mg), and Metformin Hydrochloride (500 mg), is an effective treatment for type 2 diabetes mellitus. This medication helps manage blood glucose levels through different mechanisms, offering comprehensive glycemic control. Adhering to the prescribed dosage, monitoring blood glucose levels regularly, and maintaining a healthy lifestyle can significantly enhance the benefits of this medication. While it may cause some side effects, these are generally manageable and can be minimized by following medical advice. The cost of TRIOGLIMITERIS 1/0.2 is reasonable, and with proper insurance coverage, it becomes an accessible option for many patients. Overall, TRIOGLIMITERIS 1/0.2 is a valuable tool in the management of type 2 diabetes, helping patients achieve better health outcomes and improve their quality of life. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW

SHARE WITH

  • Share via whatsapp